Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
· day one biopharmaceuticals, inc.
AI Briefing
- Servier acquires Day One Biopharmaceuticals for $2.5 billion
- Deal expands Servier's rare oncology portfolio
- Expected to close in second quarter of 2026
Advertisement